Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
BeiGene Ltd | 49B | May 16, 2024 | 11.80 | +2.61 |
Biofrontera AG | B8FK | May 16, 2024 | 3.90 | -4.87 |
Biomed-Lubin Wytwornia Surowic I Szczepionek S.A. | 6NQ | May 16, 2024 | 1.09 | -2.84 |
Biophytis | 6XB | May 16, 2024 | 0.00 | 0.00 |
Biotest AG | BIO3 | May 16, 2024 | 27.80 | +1.46 |
Bioton S.A. | 7U5 | May 16, 2024 | 0.84 | +2.44 |
Bioventix Plc | 51B | May 16, 2024 | 50.50 | +1.00 |
Bone Therapeutics S.A. | BT1 | May 16, 2024 | 0.01 | +4.62 |
Cellectis | ZVA | May 16, 2024 | 2.74 | +0.37 |
Celon Pharma SA | 8RP | May 16, 2024 | 3.75 | +0.13 |
Chromadex Corp | OCD1 | May 16, 2024 | 3.30 | -1.20 |
Circassia Group Plc | 82C | May 16, 2024 | 0.82 | -0.60 |
CKLIFE SCIENCES | LSI | May 16, 2024 | 0.05 | +1.05 |
Clinuvel Pharmaceuticals Ltd | UR9A | May 16, 2024 | 9.60 | +6.67 |
Clinuvel Pharmaceuticals Ltd Ordinary Shares (Australia) | UR9 | May 16, 2024 | 9.21 | -0.43 |
Csl Ltd SPONSORED ADR (Australia) | CSJA | May 16, 2024 | 87.00 | +1.16 |
CSL Ltd. | CSJ | May 16, 2024 | 174.62 | +1.09 |
CSTONE PHARMAC. DL-,0001 | PH4 | May 16, 2024 | 0.14 | +9.92 |
CYNATA THERAPEUTICS LTD Ordinary Shares(Australia) | 51S | May 16, 2024 | 0.14 | +5.26 |
D.Western Therapeutics Institute, Inc. | 6DW | May 16, 2024 | 0.56 | +1.83 |
Diaceutics Plc | 7DC | May 16, 2024 | 1.24 | +5.98 |
E-Therapeutics Plc | 3AQ | May 16, 2024 | 0.09 | 0.00 |
Everest Medicines Limited | 6HN | May 16, 2024 | 2.76 | 0.00 |
Evgen Pharma Plc | 8EV | May 16, 2024 | 0.00 | 0.00 |
Futura Medical | GYX | May 16, 2024 | 0.45 | +0.45 |
Galapagos NV - American Depositary Shares | GXEA | May 16, 2024 | 25.60 | +1.59 |
GeNeuro SA | GEM | May 16, 2024 | 1.49 | +6.81 |
Genoway | JEH | May 16, 2024 | 4.04 | -0.25 |
Genscript Biotech Corporation | G51 | May 16, 2024 | 1.46 | +1.39 |
GNI Group Ltd. | 3G6 | May 16, 2024 | 14.80 | -0.67 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.